Forged over decades of biomedical research
01
We expanded the universe of potential targets
10x more available cancer targets to exploit for next generation cancer therapies
02
We target the malignant cells not the healthy ones
We have designed algorithms to identify targets that maximize therapeutic index
03
AI-based antibody discovery
We use our computational framework to design highly specific antibodies for our targets
04
Hard to cure cancers
Our current focus on cancer types with low survival probability such as pancreatic cancer
Our numbers
30 K+
Targets universe
10 K+
Samples analyzed
10+
Peer-reviewed publications
2
Drug candidates under development
Get in touch
